New Paper: Terpenes for inflammatory bowel disease

by Dr. Jeremy Johnson | Posted on

A new paper was just published from our group in the journal Pharmacology and Therapeutics on terpenes for irritable bowel disease (IBD).

In this review we reviewed over 80 different phytochemicals that have been evaluated for IBD.

As a class, terpenes have the following medicinal properties: antioxidant, anti-inflammatory, anti-tumor, anti-coagulant, anti-bacterial, anti-fungal,
anti-viral, anti-parasitic, anti-aggregatory, analgesic, and sedative.

The most popular terpene-derived drugs include the anti-cancer diterpene
paclitaxel, and the anti-malarial sesquiterpene artemisinin.

You can access the article on PubMed here https://pubmed.ncbi.nlm.nih.gov/37247693/

Rivera Rodríguez R, Johnson JJ. Terpenes: Modulating anti-inflammatory signaling in inflammatory bowel disease. Pharmacol Ther. 2023 Aug;248:108456. doi: 10.1016/j.pharmthera.2023.108456. PMID: 37247693

About the author

Dr. Johnson received his PharmD and PhD at the University of Wisconsin where he also completed a clinical research fellowship evaluating phytochemicals and botanical extracts. He is an associate professor and licensed pharmacist he offers a unique perspective on the most current scientific literature related to the health and nutrition. His research program is active and has led to more than 50 publications and published abstracts related to the health promoting properties of natural products, phytochemicals and plant extracts. He has presented some of his research findings at international scientific meetings in the US, Italy, Austria, Israel, France, China, Philippines and Turkey.

Related Posts